Almost every sector has been enriched with the use of modern technology, and healthcare is no different. There are numerous medtech or health tech startups that have come up with innovative new solutions to health problems. The UK-based startup Endomag is no different. The startup offers multiple technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. It has now raised €16.73M in its latest series D funding round.
Scaling up with fresh funds
The latest funding round for Endomag was led by Draper Esprit, and it was supported by the company’s existing investors like Sussex Place Ventures, among others. Draper Espirit investment follows on its previous funding investment in Endomag’s 2018 Series C round and counting that in, Endomags’ total funding amounts to over €35.7M.